Battalion Oil Corporation has refinanced its $162.5 million senior secured credit facility by executing a new credit agreement that lowers borrowing costs by at least 125 basis points, extends debt maturity to December 2029, and defers principal payments until mid-2027. This refinancing improves financial flexibility without new cash borrowing, with existing lenders rolling over the full loan amount, signaling strong lender confidence. The company also secured up to $175 million in discretionary delayed draw capacity to fund future growth, supporting its Monument Draw development program and strategic goals. With ample liquidity from cash and reinvestment proceeds, Battalion is well-positioned to advance operations and explore additional strategic opportunities.
The global reactive hot melt adhesives market is projected to grow from $2.02 billion in 2025 to $4.29 billion by 2035, at a CAGR of 7.72%. Growth is driven by regulations limiting solvent-based adhesives, increased use of polyurethane adhesives in a...
The global automotive microcontrollers market is projected to grow from USD 15.49 billion in 2025 to USD 34.31 billion by 2035, at a CAGR of 8.28%. Growth is fueled by increasing adoption of advanced driver-assistance systems (ADAS), vehicle electrif...
CHARBONE Corporation has increased its helium delivery fleet from one to five units to meet rising demand caused by global helium supply disruptions, notably from Qatar. This expansion supports North American customers in sectors like semiconductors ...
Citi has started coverage of Hikma Pharmaceuticals with a 'buy' rating and a £17 price target, highlighting the company's strategic shift towards differentiated products and US manufacturing investments. The broker sees a 14% potential share price re...
Xenon Pharmaceuticals is evolving into a late-stage, cash-rich neuroscience company with a validated Kv7 potassium channel platform. Its lead drug candidate, azetukalner, has shown strong effectiveness in treating refractory focal onset seizures and ...
